Accelerate Your
Cell & Gene Therapy
Contract Development & Manufacturing
Accelerate Your
Cell & Gene Therapy
Contract Development & Manufacturing
At NecstGen, we enable the next generation of therapies by offering development support and GMP production of cell and gene therapies. Together, we challenge today’s possibilities and enable the unthinkable.
Are you bringing a Gene or Cell therapy to patients? We can help.
Solely dedicated to the field of Cell and Gene Therapy, we provide capacity, expertise, and services tailored accelerate the development of your therapy to the clinic and beyond. Our approach is characterised by open and transparent communication, fostering a culture of collaboration and knowledge sharing.
Cell Therapies
NecstGen offers services for Cell Therapy and Ex vivo Cell Therapy process and analytical development and manufacturing.
Viral Vectors
NecstGen provides a high-caliber process for Viral Vector manufacturing for your Gene Therapy.
Cleanroom Rental
NecstGen offers flexible GMP Cleanroom Rental at a state-of-the-art facility.
Consultancy & Support
At NecstGen, we support academic and industrial therapy developers in advancing Cell and Gene Therapies from concept to clinical reality. With our expertise on analytical and process development and manufacturing, we consult therapy developers allowing informed decision-making throughout all stages of therapy development .
“At NecstGen, we offer process development solutions, contract preclinical/ GMP manufacturing and cleanroom rental for Cell and Gene Therapies to clinicians, academic, small, medium, and large commercial organisations worldwide. We have a focused expert team and bespoke facility to offer you the support and capacity needed to deliver your therapy to patients.
We enable the next generation of therapies by translating research programs into health solutions for patients.“
News & Insights
Webinar Announcement: Improving lentiviral vector yield with 2G UNic technology
Join NecstGen and ProteoNic for our webinar “Improving lentiviral vector yield with 2G UNic...
TechTalk XL – Cell & Gene Therapies – Dutch Bio Science Week 2025
NecstGen is pleased to host the next edition of TechTalk XL during the Dutch Bio Science Week 2025 this summer. We invite you to join us for a focused afternoon of content and conversation on Cell & Gene Therapies.
NecstGen Celebrates Paul Bilars’ Five Years of Leadership
After more than five years of dedicated leadership, Paul Bilars will step down as CEO of NecstGen in July. Paul played a pivotal role in founding NecstGen and establishing it as a center of excellence for Cell and Gene Therapy.
